Mission & Vision

Mission
To manufacture and supply products that have stellar quality, and to contribute in improving the health and well-being of the population.
Vision
To lead the national pharmaceutical market, to be recognized as a multinational conglomerate from Bangladesh, and to protrude as a paradigm of efficiency and ethics in both national and international market.

Our Story

Eskayef is one of the leading pharmaceutical companies in Bangladesh with global accreditations from UK MHRA, EU GMP, VMD UK, TGA Australia, ANVISA Brazil etc. The history of Eskayef dates back to 1979, when the company was incorporated in Bangladesh, as a subsidiary of the world-renowned multinational pharmaceutical company, SK&F (SmithKline & French, USA).

In 1990, the Bangladesh operation of SK&F was acquired by Transcom Group, in the wake of the merge between SmithKline & French, USA and Beecham, UK. That was the first incidence of taking over of a multinational company by a Bangladeshi establishment. After the acquisition, the new company was named Eskayef Bangladesh Limited. As Eskayef continued to increase its global presence, in 2017 it was renamed as Eskayef Pharmaceuticals Ltd. At present, Eskayef has global presence in 65 countries across Europe, America, Australia, Africa and Asia.

Eskayef manufactures and markets a wide range of therapeutic drugs, bulk pellets, and animal health and nutrition products. Over the years, it has emerged as one of the most trusted, quality-driven, and scientific information-based companies in the eyes of health care professionals and patients.

History
1979

In 1979, the company was incorporated in Bangladesh as a subsidiary of the world-renowned multinational pharmaceutical company SmithKline & French (SK&F), USA.

SmithKline & French (SK&F), USA.
1990

In 1990, SmithKline & French's Bangladesh operation was acquired by Transcom Group in the wake if the merger between SmithKline & French, USA and Beecham, UK. That was the first instance of taking over of any multinational company by a Bangladeshi entity. After the acquisition, the new company was named as Eskayef Bangladesh Limited.

Eskayef Bangladesh Limited.
2017

In 2017, As Eskayef continued to increase its presence in the international arena, this led to the company emerging as, Eskayef Pharmaceuticals Limited.

Eskayef Pharmaceuticals Limited.

Founder Chairman

chairman photo

Latifur Rahman

Aug 28, 1945 – July 01, 2020

Founder Chairman
  • Transcom Group
Former Executive Member
  • International Chamber of Commerce (ICC)
Former Vice President
  • ICC Bangladesh
Former Executive Member
  • Nestle Bangladesh Limited, Holcim Cement Bangladesh Limited
Former President
  • Metropolitan Chamber of Commerce and industry, Dhaka
Former Member Governing Body
  • BRAC (World's Largest NGO)

Accolades

skf-latifur-rahman-logo skf-latifur-rahman-logo skf-latifur-rahman-logo
chairman photo

Managing Director & CEO

We will continue our journey, staying true to our values, facing challenges with lionhearted bravery and with unstinting determination to outdo all expectations.

We must convert our passion into the driving force to take ourselves to newer heights and create history.

Simeen Rahman

Managing Director & CEO

Eskayef Pharmaceuticals Limited

We will continue our journey, staying true to our values, facing challenges with lionhearted bravery and with unstinting determination to outdo all expectations.
We must convert our passion into the driving force to take ourselves to newer heights and create history.
Simeen Rahman

Managing Director & CEO

Eskayef Pharmaceuticals Limited

Core Values

People

Cornerstone of our success

Quality

Prevention rather than detection

ETHICS

Integrity in every step
Click to read Human Rights Policy

COURAGE

Doing the right thing

Excellence

Acquiring success through excellence

Executive Management

team image
Simeen Rahman

Managing Director & CEO

team image
MOHAMMAD MOSTAFA HASSAN

Executive Director, Commercial & HR

team image
KAZI MAHBUB MASUD

Executive Director, Finance

team image
MD. MOTIAR RAHMAN

Executive Director, Quality Assurance

team image
ABDULLAH AL WAHID

Executive Director, Plant

team image
K. M. ARIFUL ISLAM

Executive Director, Plant

team image
MOHAMMAD IKHTIAR HOSSAIN

Executive Director, Technical

team image
DR. MOHAMMAD MUJAHIDUL ISLAM

Executive Director, Marketing and Sales

Key Milestones

  1. Eskayef achieves the most prestigious US FDA approval.
  2. Introduction of Monuvir, the first generic Molnupiravir in the world.
    Introduction of Paxovir, the first generic version of combination of
    Nirmatrelvir and Ritonavir to treat Covid-19.
    Eskayef achieves accreditations from ANVISA Brazil.
  3. Introduction of Remivir, 1st ever generic Remdesivir brand in the world.
    Eskayef Oncology plant receives the stringent EU GMP approval.
    Eskayef establishes its world class dedicated R&D center.
  4. To combat cancer, Eskayef establishes dedicated Oncology Plant
    with ISOLATOR Technology, first time in Bangladesh.
  5. Becomes the 1st in the country to develop a dedicated Carbapenem Facility.
    Introduction of MUPS, MDI & Effervescent Technology.
  6. Commissioning of Rupganj Plant
  7. Eskayef achieves re-accreditations from TGA, Australia.
  8. Eskayef achieves re-accreditations from UK MHRA.
    Novo Nordisk audit with zero observation.
  9. Eskayef ventures into Ophthalmic Production.
  10. Eskayef achieves accreditations from VMD UK.
    Starts manufacturing Insulin for Novo Nordisk.
    Starts production of Large Volume Parenterals.
  11. Eskayef achieves accreditations from TGA, Australia.
    Commissioning of Liquid Sterile Unit at Tongi.
  12. Eskayef achieves accreditations from UK MHRA & EU GMP.
    Commissioning of Dedicated Cephalosporin Plant.
  13. Entry into International Business.
    Commencement of production from Tongi Plant.
  14. Acquisition of Squibb Plant at Tongi.
    Commencement of Animal Health Business.
  15. Eskayef becomes the trailblazer for ‘Pellet Technology’ in Bangladesh.
  16. Eskayef starts its journey from the Mirpur Plant